Solara Active Pharma Sciences Hits Upper Circuit Limit Amid Positive Sector Trends
2025-04-03 11:00:21Solara Active Pharma Sciences Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has made headlines today by hitting its upper circuit limit. The stock reached an intraday high of Rs 556.7, reflecting a 5% increase from its previous trading session. This surge comes as the stock recorded a change of Rs 7.7, translating to a 1.45% increase. Despite underperforming its sector by 0.8%, Solara has shown resilience with a consecutive gain over the last two days, accumulating a total return of 5.18% during this period. The total traded volume today was approximately 0.67855 lakh shares, resulting in a turnover of Rs 3.70 crore. The last traded price stood at Rs 537.9, with a low of Rs 530.2 noted during the trading session. In terms of moving averages, the stock is currently above its 5-day, 20-day, and 50-day averages, although it remains below the 100-day and 200-day averages. The Pharmaceuticals ...
Read MoreSolara Active Pharma Sciences Faces Mixed Technical Trends Amid Market Fluctuations
2025-04-03 08:06:09Solara Active Pharma Sciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 525.00, showing a notable increase from the previous close of 511.65. Over the past year, Solara has demonstrated a return of 31.74%, significantly outperforming the Sensex, which recorded a return of 3.67% in the same period. In terms of technical indicators, the weekly MACD remains bearish, while the monthly perspective shows a mildly bearish trend. The Relative Strength Index (RSI) indicates no signal for both weekly and monthly assessments. Bollinger Bands present a mildly bearish outlook on a weekly basis, contrasting with a bullish stance on a monthly scale. Daily moving averages also reflect a mildly bearish trend. The company's performance over various time frames reveals a mixed picture. Whil...
Read More
Solara Active Pharma Sciences Faces Technical Shift Amid Mixed Financial Performance
2025-04-02 08:39:03Solara Active Pharma Sciences has experienced a recent evaluation adjustment due to shifts in technical indicators, reflecting a bearish sentiment. Despite a slight increase in net profit and positive quarterly results, the company faces challenges with declining operating profit, high debt levels, and low return on equity, complicating its financial outlook.
Read MoreSolara Active Pharma Faces Diverging Technical Trends Amid Market Challenges
2025-04-02 08:09:30Solara Active Pharma Sciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 511.65, slightly down from the previous close of 512.70. Over the past year, Solara has experienced a notable return of 34.67%, significantly outperforming the Sensex, which recorded a return of 2.72% in the same period. In terms of technical indicators, the weekly MACD and Bollinger Bands suggest a bearish sentiment, while the monthly KST shows a contrasting bullish trend. The stock's moving averages indicate a bearish stance on a daily basis, contributing to the overall technical summary. Notably, the Relative Strength Index (RSI) shows no signal for both weekly and monthly periods, indicating a lack of momentum in either direction. When comparing the stock's performance to the Sensex, Solara's year...
Read MoreSolara Active Pharma Sciences Faces Market Challenges Amid Significant Trading Activity
2025-03-25 14:00:08Solara Active Pharma Sciences Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, experienced significant trading activity today, hitting its lower circuit limit. The stock closed at Rs 528.9, reflecting a decline of Rs 22.5 or 4.08% from the previous trading session. Notably, it reached an intraday low of Rs 523.85, marking a 5% drop. The stock's performance today underperformed its sector by 2.81%, following a trend reversal after two consecutive days of gains. The total traded volume was approximately 0.63491 lakh shares, resulting in a turnover of Rs 3.38 crore. The weighted average price indicated that more volume was traded closer to the low price, suggesting a shift in market sentiment. In terms of moving averages, Solara's stock is currently above the 5-day and 20-day averages but below the 50-day, 100-day, and 200-day averages. The stock's liquidity remains adequate, with a delivery ...
Read MoreSolara Active Pharma Sciences Experiences Surge in Trading Activity and Market Interest
2025-03-24 10:01:26Solara Active Pharma Sciences Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has made headlines today by hitting its upper circuit limit. The stock reached an intraday high of Rs 554, reflecting a notable increase of 4.4% from its previous close. The last traded price stands at Rs 530.65, marking a change of Rs 25.25 or 5.0% for the day. Trading activity has been robust, with a total traded volume of approximately 0.72939 lakh shares and a turnover of Rs 3.84 crore. The stock has shown consistent performance, gaining 6.13% over the last two days and outperforming its sector by 0.52% today. It opened with a gap up of 3.27%, indicating strong market interest. In terms of price dynamics, the stock is currently above its 5-day and 20-day moving averages, although it remains below the longer-term averages of 50, 100, and 200 days. Despite a slight decline in delivery volume, the liquidity remai...
Read MoreSolara Active Pharma Sciences Sees Strong Buying Activity and Notable Price Gains
2025-03-21 10:50:13Solara Active Pharma Sciences Ltd is witnessing significant buying activity, with the stock rising by 5.07% today, outperforming the Sensex, which gained only 0.59%. Over the past week, Solara has shown a robust performance with a 10.54% increase compared to the Sensex's 4.02%. In the last month, the stock has risen by 8.25%, while the Sensex recorded a modest 1.98% gain. Despite a challenging three-month period where Solara's stock declined by 23.09%, it has rebounded impressively over the past year, boasting a 43.94% increase against the Sensex's 5.72%. However, year-to-date and three-year performances remain negative at -21.50% and -21.13%, respectively, contrasting sharply with the Sensex's positive trajectory. Today's trading saw Solara reach an intraday high of Rs 530.6, reflecting strong buyer sentiment. The stock's current price is above its 5-day and 20-day moving averages, indicating short-term ...
Read MoreSolara Active Pharma Sciences Ltd Achieves Upper Circuit Limit Amid Strong Trading Activity
2025-03-21 10:00:40Solara Active Pharma Sciences Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has made headlines today as its stock hit the upper circuit limit. The stock reached an impressive intraday high of Rs 530.65, reflecting a notable change of Rs 19.55 or 3.87% from its last traded price of Rs 524.95. The stock's performance today outpaced its sector by 3.23%, showcasing its strength in a competitive market. With a total traded volume of approximately 0.39 lakh shares and a turnover of Rs 2.04 crore, the trading activity indicates a robust interest in the stock. The price band for the day was set at 5%, allowing for significant movement within the trading session. In terms of moving averages, Solara's stock is currently above its 5-day and 20-day averages, although it remains below the 50-day, 100-day, and 200-day averages. Despite a slight decline in delivery volume, the stock maintains adequat...
Read MoreSolara Active Pharma Sciences Sees Strong Buying Activity Amid Price Gains
2025-03-19 13:30:11Solara Active Pharma Sciences Ltd is currently witnessing significant buying activity, with the stock gaining 4.66% today, outperforming the Sensex, which rose by only 0.26%. Over the past week, Solara has shown a 4.13% increase, compared to the Sensex's 1.98%. Notably, the stock has experienced consecutive gains over the last two days, accumulating a total return of 7.47%. In terms of price performance, Solara reached an intraday high of Rs 508.45 today. The stock's performance over the past month has been particularly strong, with a 10.62% increase, while the Sensex has declined by 0.58% during the same period. However, the stock's longer-term performance shows a decline of 29.87% over the past three months, contrasting with the Sensex's drop of 4.70%. Several factors may be contributing to the current buying pressure, including recent developments in the pharmaceutical sector and potential market senti...
Read MoreAnnouncement under Regulation 30 (LODR)-Meeting Updates
02-Apr-2025 | Source : BSESolara Active Pharma Sciences Limited informed the exchange about the outcome of the Rights Issue Committee Meeting held today (i.e.) April 02 2025 interalia to consider and approve the First call money notice to be sent to the eligible shareholders
Board Meeting Outcome for Outcome Of The Rights Issue Committee Meeting_Solara Active Pharma Sciences Limited
02-Apr-2025 | Source : BSEOutcome: Solara Active Pharma Sciences Limited informed the exchange about the Rights Issue Committee Meeting held today (i.e.) on April 02 2025 interalia to consider and approve the First call money notice to be sent to the eligible shareholders.
Board Meeting Outcome for Intimation Under Regulation 30 And 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
26-Mar-2025 | Source : BSESolara Active Pharma Sciences Limited has informed the Exchange that Board of Directors at its meeting held on March 26 2025 has approved the making of first call of Rs. 3.50/- each (i.e.) 35% on the face value of Rs. 10/- each on the outstanding 11998755 partly paid-up equity shares of the Company which were allotted on June 19 2024 on a right basis fixation of Record date Tendering period and other matters.
Corporate Actions
No Upcoming Board Meetings
Solara Active Pharma Sciences Ltd has declared 30% dividend, ex-date: 18 Aug 21
No Splits history available
No Bonus history available
Solara Active Pharma Sciences Ltd has announced 1:3 rights issue, ex-date: 15 May 24